✦ LIBER ✦

Use of Capecitabine as First-Line Therapy in Patients with Metastatic Breast Cancer Relapsing After High- Dose Chemotherapy and Autologous Stem Cell Support

✍ Scribed by A. Bashey; S. Sundaram; S. Corringham; V. Jones; D. Lancaster; J. Silva-Gietzen; P. Law; E.D. Ball

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose chemotherapy with autologous s

✍ Lois J. Ayash 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 1 views

High-dose therapy with autologous hemato

✍ Bearman, S I; Vredenburgh, J J; Cagnoni, P J; Shpall, E J; Nieto, Y; Ross, M; Pe 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 42 KB

Stem Cell Dose and Tumorbiologic Paramet

✍ Manfred Hensel; Andreas Schneeweiss; Hans-Peter Sinn; Gerlinde Egerer; Martin Ko 📂 Article 📅 2002 🏛 AlphaMed Press 🌐 English ⚖ 121 KB

HER2 overexpression as a prognostic fact

✍ Guarneri, V; Bengala, C; Orlandini, C; Gennari, A; Donati, S; Campani, D; Collec 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 124 KB

Comparison of Double and Triple High-Dos

✍ A. Schneeweiss; M. Hensel; R. Goerner; T. Khbeis; S. Hohaus; G. Egerer; E. Solom 📂 Article 📅 2001 🏛 AlphaMed Press 🌐 English ⚖ 70 KB

Expression of C-erbB-2/HER-2 in patients

✍ Bewick, M; Chadderton, T; Conlon, M; Lafrenie, R; Morris, D; Stewart, D; Glück, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB